Test Code LAB90325 Amikacin, Peak/Post-Dose, Plasma or Serum
Additional Codes
45049
Reporting Title
Amikacin Post Dose
Methodology
Roche Diagnostics
Performing Laboratory
OhioHealth Laboratory Services-RMH Core Chemistry
Specimen Requirements
Submit only 1 of the following specimens:
Preferred:
Serum
Draw blood in a Gold-top serum gel tube(s), 60 minutes after an intravenous infusion (intravenous piggyback [IVPB] conventional dosing).
Note: 1. Date and time of draw
are required on request form and specimen for
processing.
2. A speckled-top serum gel tube(s) or plain red-top is also acceptable.
3. Indicate serum and peak/post-dose on request form.
4. Label specimen appropriately (serum and as peak/post-dose).
Alternate:
Plasma
Draw blood in a mint green-top (heparin) gel tube(s) 60 minutes after an intravenous infusion (intravenous piggyback [IVPB] conventional dosing).
Note: 1. Date and time of draw are required on request form and specimen for processing.
2. Indicate plasma and peak/post-dose on request form.
3. Label specimen appropriately (plasma and as peak/post-dose).
Sample Stability Information:
Specimen Type | Temperature | Time |
---|---|---|
Serum or plasma | Refrigerated | 48 hours capped |
Ambient | 8 hours capped | |
Frozen | 4 weeks capped |
Specimen Transport Temperature
Frozen/Ambient OK/Refrigerate OK
Reference Values
20-30 mcg/mL
Critical value >30 mcg/mL
Alerting category: Always called within 1 hour
Note: Kanamycin has significant crossreactivity. If patient is receiving kanamycin, the amikacin test will be invalid.
Day(s) Test Set Up
Monday through Sunday; Continuously
Test Classification and CPT Coding
80150